Further to the recent announcement of the visit by Victoria Gorbacheva, MD PhD, the Head of Business Development in Russia of Berlin-Chemie/Menarini Pharma GmbH, the Directors of Solagran Limited (ASX: SLA) are very pleased to announce the intended path forward following a week of intense and productive meetings.
HELICON GROUP LIMITED (ASX: HCG) is pleased to announce the appointment of Anita Wehrli to the position of Business Development Manager based in Switzerland.
HELICON GROUP LIMITED (ASX: HCG) today announced the appointment of Aleksandra Gajda to the position of Stakeholder Relations Manager.
The Directors of Solagran Limited are pleased to announce that Ms Victoria Gorbacheva, the Business Development & Marketing Director of Berlin-Chemie/Menarini Pharma GmbH, part of the international Menarini Pharmaceutical group, is visiting Melbourne to further progress ongoing discussions in relation to the licencing, marketing and distribution of Ropren
SciGen Limited (ASX: SIE) announces that it has been awarded the GMP certification of its manufacturing facility in Rehovot, Israel where its third generation hepatitis B vaccine Sci B Vac is manufactured. This comes after having successfully implemented and complied with all the requirements as specified by the World Health Organisation (WHO) and the Ministry of Health of Israel.
Eastland Medical Systems Ltd (ASX: EMS) remains on track with the development of its anti-malaria treatment ArTiMistTM and will commence a multi dose Phase 1 clinical trial for ArTiMistTM in February, after its Pharmaceutical Division receiving approval from the South African MCC Regulatory Body.
The Directors are pleased to announce that Solagran Limited (ASX: SLA) has engaged the Bank of New York to establish a level one American Depository Receipt (ADR) Program.
